Name | 19-Dehydroursolsaeure |
---|---|
Synonyms | (6aS,12bR)-10-Hydroxy-1,2,6a,6b,9,9,12a-heptamethyl-3,5,6,6a,6b,7,8,8a,9,10,11,12,12a,12b,13,14b-hexadecahydro-4H-picene-4a-carboxylic acid |
Description | Sanguisorbigenin is a natural antibacterial agent that inhibits methicillin-resistant S. aureus (MRSA)[1]. |
---|---|
Related Catalog | |
In Vitro | The minimal inhibitory concentration values of Sanguisorbigenin against six strains of S. aureus are in the range of 12.5-50 μg/mL[1]. The expression of blaR1, mecA and blaZ is significantly inhibited in MRSA in a dose-dependent manner when it is treated with sub-MIC (1.56-6.25 μg/mL) concentrations of Sanguisorbigenin. Sanguisorbigenin remarkably reduces the gene expression of mecA. Sanguisorbigenin has a potent antibacterial effect and could effectively reverse the sense of antibiotics by inhibiting the mecA expression and decrease PBP2a expression[1]. |
References |
Molecular Formula | C30H46O3 |
---|---|
Molecular Weight | 454.68400 |
Exact Mass | 454.34500 |
PSA | 57.53000 |
LogP | 7.15370 |